NCT00464165 - Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation | Biotech Hunter

Enrollment

789

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Smoking Cessation

Interventions

DRUG

rimonabant

Trial Locations (7)

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Hørsholm

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Bromma

Sanofi-Aventis Administrative Office, Geneva

Sanofi-Aventis Administrative Office, Guildford